The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

The trailblazing study will use the data from up to 1.4million NHS patients to test whether its shingles vaccine reduces the ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and ...

American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American ...

Auckland deputy mayor Desley Simpson recently suffered from a painful shingles infection she likened to having "a hedgehog ...

High tea to benefit Neumann’s Cultural Arts Forum, Hooters drummer to speak at Tasty Talks Luncheon, Upper Darby High School ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...